180 Life Sciences (ATNF) Short Interest Ratio & Short Volume $1.33 +0.44 (+49.44%) Closing price 05/1/2025 03:59 PM EasternExtended Trading$1.35 +0.02 (+1.50%) As of 04:13 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock 180 Life Sciences Short Interest Data180 Life Sciences (ATNF) has a short interest of 119,300 shares, representing 13.02% of the float (the number of shares available for trading by the public). This marks a 107.84% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.3, indicating that it would take 1.3 days of the average trading volume of 808,430 shares to cover all short positions.Current Short Interest119,300 sharesPrevious Short Interest57,400 sharesChange Vs. Previous Month+107.84%Dollar Volume Sold Short$106,177.00Short Interest Ratio1.3 Days to CoverLast Record DateApril 15, 2025Outstanding Shares5,186,000 sharesFloat Size916,100 sharesShort Percent of Float13.02%Today's Trading Volume3,053,488 sharesAverage Trading Volume808,430 sharesToday's Volume Vs. Average378% Short Selling 180 Life Sciences? Sign up to receive the latest short interest report for 180 Life Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartATNF Short Interest Over TimeATNF Days to Cover Over TimeATNF Percentage of Float Shorted Over Time 180 Life Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2025119,300 shares $106,177.00 +107.8%13.0%1.3 $0.89 3/31/202557,400 shares $58,835.00 +2.5%4.2%0.4 $1.03 3/15/202556,000 shares $59,920.00 +67.2%4.1%0.1 $1.07 2/28/202533,500 shares $39,195.00 +29.3%2.4%0.1 $1.17 2/15/202525,900 shares $34,447.00 -50.4%1.5%0.1 $1.33 1/31/202552,200 shares $73,080.00 -63.2%3.1%0.1 $1.40 1/15/2025141,800 shares $232,552.00 +11.7%8.4%0.2 $1.64 12/31/2024126,900 shares $230,958.00 -21.1%7.6%0.1 $1.82 12/15/2024160,800 shares $310,344.00 +148.2%31.4%0.1 $1.93 11/30/202464,800 shares $144,504.00 -28.6%13.2%0 $2.23 Get the Latest News and Ratings for ATNF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for 180 Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 11/15/202490,800 shares $227,000.00 -34.9%18.5%0 $2.50 10/31/2024139,400 shares $546,448.00 +77.1%28.5%0.1 $3.92 10/15/202478,700 shares $119,624.00 +7.4%16.1%0 $1.52 9/30/202473,300 shares $123,877.00 +21.0%14.1%0.8 $1.69 9/15/202460,600 shares $109,686.00 +78.8%11.7%0.1 $1.81 8/31/202433,900 shares $61,359.00 +5.3%6.5%0.1 $1.81 8/15/202432,200 shares $60,536.00 -29.7%6.2%0.1 $1.88 7/31/202445,800 shares $95,264.00 -67.5%8.8%0.1 $2.08 7/15/2024140,800 shares $285,824.00 +249.4%27.2%0.2 $2.03 6/30/202440,300 shares $66,495.00 +13.2%7.8%0.1 $1.65 6/15/202435,600 shares $55,180.00 -19.8%6.9%0.3 $1.55 5/31/202444,400 shares $71,928.00 +156.7%8.6%0.3 $1.62 5/15/202417,300 shares $33,562.00 -36.9%3.4%0.1 $1.94 4/30/202427,400 shares $58,910.00 +60.2%5.3%0.3 $2.15 4/15/202417,100 shares $34,542.00 -59.7%3.3%0.2 $2.02 3/31/202442,400 shares $98,792.00 -31.4%8.4%0.4 $2.33 3/15/202461,800 shares $216,300.00 +309.3%12.2%0.6 $3.50 2/29/202415,100 shares $53,152.00 -95.6%3.0%0.2 $3.52 2/15/2024342,100 shares $1.36 million -22.8%3.6%0.3 $3.99 1/31/2024443,300 shares $94,866.20 -61.8%4.6%0.4 $0.21 1/15/20241,160,000 shares $234,552.00 +195.7%12.2%1 $0.20 12/31/2023392,300 shares $83,756.05 -32.9%4.1%0.4 $0.21 12/15/2023584,700 shares $109,923.60 -4.0%6.2%1 $0.19 11/30/2023608,900 shares $165,011.90 +281.3%8.8%1.2 $0.27 11/15/2023159,700 shares $57,476.03 +26.1%2.3%1.2 $0.36 10/31/2023126,700 shares $54,481.00 +21.2%2.3%0.9 $0.43 10/15/2023104,500 shares $58,509.55 -37.3%1.9%0.3 $0.56 9/30/2023166,700 shares $102,103.75 +64.7%3.0%0.5 $0.61 9/15/2023101,200 shares $83,712.64 -30.1%1.8%0.3 $0.83 8/31/2023144,800 shares $96,581.60 -77.1%2.6%0.5 $0.67Massive new energy source found in Utah (Ad)NEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millions of years. And both grizzled oilmen and clean energy supporters love it: Energy Secretary Chris Wright called it "an awesome resource," while Warren Buffett, Jeff Bezos, Mark Zuckerberg, and Bill Gates are all directly invested.Find out what billionaires already know about this new energy source 8/15/2023632,100 shares $453,847.80 +3,108.6%11.2%1.9 $0.72 7/31/202319,700 shares $18,518.00 -34.8%0.4%0 $0.94 7/15/202330,200 shares $31,408.00 -46.4%0.6%0.1 $1.04 6/30/202356,300 shares $65,871.00 -52.3%1.1%0.1 $1.17 6/15/2023118,000 shares $136,880.00 -27.4%2.4%0.1 $1.16 5/31/2023162,500 shares $185,250.00 +70.3%3.4%0.2 $1.14 5/15/202395,400 shares $98,262.00 -13.2%2.0%0.1 $1.03 4/30/2023109,900 shares $126,385.00 -51.7%2.4%0.2 $1.15 4/15/2023227,500 shares $282,100.00 +106.6%7.2%0.2 $1.24 3/31/2023110,100 shares $198,180.00 +56.0%3.5%0.1 $1.80 3/15/202370,600 shares $146,142.00 -59.2%4.6%0 $2.07 2/28/2023173,000 shares $496,510.00 -7.2%11.2%0 $2.87 2/15/2023186,400 shares $561,064.00 -52.7%11.2%0 $3.01 1/31/2023393,900 shares $1.31 million -26.6%23.6%0.1 $3.33 1/15/2023536,900 shares $1.99 million +3.0%32.2%0.1 $3.71 12/30/2022521,100 shares $1.77 million +1,060.6%31.2%0.1 $3.39 12/15/202244,900 shares $243,986.60 -94.9%2.8%0.1 $5.43 11/30/2022874,900 shares $367,458.00 -0.2%N/A4.4 $0.42 11/15/2022876,800 shares $380,881.92 -3.4%N/A4.6 $0.43 10/31/2022907,300 shares $424,797.86 -11.1%N/A4.2 $0.47 10/15/20221,020,000 shares $520,404.00 +1.0%N/A4.9 $0.51 9/30/20221,010,000 shares $671,650.00 +2.0%N/A4.7 $0.67 9/15/2022990,000 shares $801,999.00 -2.0%N/A5.6 $0.81 8/31/20221,010,000 shares $859,914.00 +9.8%N/A4.7 $0.85 8/15/2022919,500 shares $1.05 million -1.7%N/A3.4 $1.14 7/31/2022935,700 shares $1.02 million +3.9%N/A3.3 $1.09 7/15/2022900,500 shares $1.03 million -8.0%N/A2 $1.14 6/30/2022978,400 shares $829,683.20 -13.4%N/A2.1 $0.85 6/15/20221,130,000 shares $998,920.00 -18.7%N/A2.3 $0.88 5/31/20221,390,000 shares $2.25 million -0.7%N/A3.2 $1.62 5/15/20221,400,000 shares $1.76 million +5.3%N/A3.6 $1.26 4/30/20221,330,000 shares $2.82 million -1.5%N/A3.4 $2.12 4/15/20221,350,000 shares $2.65 million -6.3%N/A4.7 $1.96 3/31/20221,440,000 shares $3.73 million -4.0%N/A4.6 $2.59 3/15/20221,500,000 shares $3.87 million +5.6%N/A4.2 $2.58 2/28/20221,420,000 shares $4.53 million -6.6%N/A2.9 $3.19 2/15/20221,520,000 shares $4.97 million +13.4%N/A1.8 $3.27 1/31/20221,340,000 shares $3.83 million -8.8%N/A1.4 $2.86 1/15/20221,470,000 shares $4.47 million -7.0%N/A1.5 $3.04 12/31/20211,580,000 shares $6.16 million -18.1%N/A1.6 $3.90 12/15/20211,930,000 shares $7.86 million +37.9%N/A2 $4.07 11/30/20211,400,000 shares $8.93 million +2.2%N/A1.3 $6.38 11/15/20211,370,000 shares $5.86 million -16.0%N/A1.8 $4.28 10/29/20211,630,000 shares $8.26 million +16.4%N/A2.4 $5.07 10/15/20211,400,000 shares $7.85 million -4.8%N/A1.9 $5.61 9/30/20211,470,000 shares $7.95 million -33.8%N/A2.1 $5.41 9/15/20212,220,000 shares $14.65 million +14.4%N/A3.3 $6.60 8/31/20211,940,000 shares $11.43 million +116.6%N/A3.9 $5.89 8/13/2021895,800 shares $6.96 million -60.5%N/A2 $7.77 7/30/20212,270,000 shares $17.18 million +3.2%20.3%5.7 $7.57Massive new energy source found in Utah (Ad)NEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millions of years. And both grizzled oilmen and clean energy supporters love it: Energy Secretary Chris Wright called it "an awesome resource," while Warren Buffett, Jeff Bezos, Mark Zuckerberg, and Bill Gates are all directly invested.Find out what billionaires already know about this new energy source 7/15/20212,200,000 shares $20.17 million -0.5%19.7%5.7 $9.17 6/30/20212,210,000 shares $22.10 million -1.3%24.2%1.7 $10.00 6/15/20212,240,000 shares $22.92 million +2.8%24.6%1 $10.23 5/28/20212,180,000 shares $18.62 million -15.5%23.9%0.9 $8.54 5/14/20212,580,000 shares $17.67 million -9.8%28.3%1 $6.85 4/30/20212,860,000 shares $29.66 million -5.6%31.4%1.1 $10.37 4/15/20213,030,000 shares $31.69 million +25.7%33.2%1 $10.46 3/31/20212,410,000 shares $14.80 million +6.2%26.4%0.8 $6.14 3/15/20212,270,000 shares $14.48 million +6.1%83.5%1.3 $6.38 2/26/20212,140,000 shares $9.44 million +364.0%78.7%1.3 $4.41 2/12/2021461,200 shares $2.73 million +54.6%17.0%0.3 $5.91 1/29/2021298,300 shares $1.04 million -1.8%11.0%0.2 $3.48 1/15/2021303,900 shares $948,168.00 No Change11.2%0.3 $3.12 ATNF Short Interest - Frequently Asked Questions What is 180 Life Sciences' current short interest? Short interest is the volume of 180 Life Sciences shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 119,300 shares of ATNF short. 13.02% of 180 Life Sciences' shares are currently sold short. Learn More on 180 Life Sciences' current short interest. What is a good short interest ratio for 180 Life Sciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ATNF shares currently have a short interest ratio of 1.0. Learn More on 180 Life Sciences's short interest ratio. What is a good short interest percentage for 180 Life Sciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.02% of 180 Life Sciences' floating shares are currently sold short. Is 180 Life Sciences' short interest increasing or decreasing? 180 Life Sciences saw a increase in short interest in April. As of April 15th, there was short interest totaling 119,300 shares, an increase of 107.8% from the previous total of 57,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is 180 Life Sciences' float size? 180 Life Sciences currently has issued a total of 5,186,000 shares. Some of 180 Life Sciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. 180 Life Sciences currently has a public float of 916,100 shares. How does 180 Life Sciences' short interest compare to its competitors? 13.02% of 180 Life Sciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to 180 Life Sciences: Allarity Therapeutics, Inc. (11.15%), Lipocine Inc. (1.39%), MIRA Pharmaceuticals, Inc. (3.96%), Cingulate Inc. (4.50%), Upexi, Inc. (5.92%), GlycoMimetics, Inc. (3.34%), Edesa Biotech, Inc. (0.90%), Cocrystal Pharma, Inc. (0.09%), Bullfrog AI Holdings, Inc. (7.34%), Equillium, Inc. (1.10%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short 180 Life Sciences stock? Short selling ATNF is an investing strategy that aims to generate trading profit from 180 Life Sciences as its price is falling. ATNF shares are trading up $0.44 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against 180 Life Sciences? A short squeeze for 180 Life Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ATNF, which in turn drives the price of the stock up even further. How often is 180 Life Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATNF, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies Allarity Therapeutics Short Squeeze Lipocine Short Squeeze MIRA Pharmaceuticals Short Squeeze Cingulate Short Squeeze Upexi Short Squeeze GlycoMimetics Short Squeeze Edesa Biotech Short Squeeze Cocrystal Pharma Short Squeeze Bullfrog AI Short Squeeze Equillium Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ATNF) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 180 Life Sciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share 180 Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ATNF Stock Free ATNF Stock Alerts